Susan Hasty, Publisher
Table of Contents . . . February 15th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Blood Weekly | Other Publications
Severe Acquired Aplastic Anemia - Bone Marrow Transplant Still Best Option
Thrombosis - Tissue-Type Plasminogen Activator Mutants Shed Light on Fibrinolysis Regulators
Anticoagulation - Oral Formulations May Reduce Heart Attacks and Death
Bone Marrow Transplantation - Cytotoxic T-lymphocyte Precursor Frequency Can Help Predict Safe HLA-Mismatches
Hemodialysis - Atrial Fibrillation Can Lead to Thromboembolic Morbidity
Hemostasis - Excessive Sympathetic Nervous System Activity Dangerous in Some Patients
Anemia - Mitochondrial Dysfunction Implicated in Blood Cell Apoptosis
Anemia - No Unexpected Long-Term Consequences After Bone Marrow Transplantation
Arterial Stiffening - Drug Decreases Blood Vessel Stiffness in Older Primates
Bone Marrow Transplantation - Routine Graft-Versus-Host Disease Therapy May Be Unnecessary
Diagnostics - New Methods Identifies Cytotoxic T Lymphocyte Response to HCV in Blood
Intimal Hyperplasia - Shear Force Modulates Metalloproteinases and Hyperplasia within Veins
Lead Testing - Poor, Minority Children Less Likely to be Screened
Leukemia - Autologous T Lymphocytes Specifically Recognize Leukemic B Cells
Leukemia - Interferon-(alpha) Therapy Gets a Boost
Leukemia - Vincristine Selectively Targets Malignant Cells for Apoptosis
Malaria - DNA Immunization Induces Protective Immunity Against Plasmodium falciparum
Stem Cell Transplantation - Post-Grafting Telomere Loss Not Significant
Stem Cells - Neutrophil Respiratory Burst Not Crucial for Migration
Stroke - Hormone Replacement Therapy Does Not Increase Risk
Stroke - Scientists Suggest Therapy Targets Tissue Damage Prevention
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.